97 related articles for article (PubMed ID: 8529300)
21. The effect of increasing dialysis dose in overweight hemodialysis patients on quality of life: a 6-week randomized crossover trial.
Wang W; Tonelli M; Hemmelgarn B; Gao S; Johnson JA; Taub K; Manns B;
Am J Kidney Dis; 2008 May; 51(5):796-803. PubMed ID: 18436090
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacokinetics of 3'-azido-3 deoxy-thymidine (AZT) in a patient undergoing hemodialysis].
Deray G; Diquet B; Martinez F; Vidal AM; Petitclerc T; Land G; Raymond F; Baumelou A; Jacobs C
Therapie; 1989; 44(6):405-8. PubMed ID: 2623654
[TBL] [Abstract][Full Text] [Related]
23. Iodine-131 pharmacokinetics in patients on hemodialysis for end stage renal disease: clinical implications.
Courbon F; Caselles O; Zerdoud S; Duthil P; Regis H; Berry I; Caron P
Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):363-70. PubMed ID: 17043635
[TBL] [Abstract][Full Text] [Related]
24. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
Dierkes J; Domröse U; Ambrosch A; Bosselmann HP; Neumann KH; Luley C
Clin Nephrol; 1999 Feb; 51(2):108-15. PubMed ID: 10069646
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
[TBL] [Abstract][Full Text] [Related]
26. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
Dager WE; King JH
Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of thalidomide in patients with impaired renal function and while on and off dialysis.
Eriksson T; Höglund P; Turesson I; Waage A; Don BR; Vu J; Scheffler M; Kaysen GA
J Pharm Pharmacol; 2003 Dec; 55(12):1701-6. PubMed ID: 14738599
[TBL] [Abstract][Full Text] [Related]
28. Rubidium deficiency in dialysis patients.
Canavese C; DeCostanzi E; Branciforte L; Caropreso A; Nonnato A; Pietra R; Fortaner S; Jacono F; Angelini G; Gallieni M; Fop F; Sabbioni E
J Nephrol; 2001; 14(3):169-75. PubMed ID: 11439740
[TBL] [Abstract][Full Text] [Related]
29. Elimination and clearance of pamidronate by haemodialysis.
Buttazzoni M; Rosa Diez GJ; Jager V; Crucelegui MS; Algranati SL; Plantalech L
Nephrology (Carlton); 2006 Jun; 11(3):197-200. PubMed ID: 16756631
[TBL] [Abstract][Full Text] [Related]
30. [Clinical and analytical changes in hemodialysis without acetate].
Coll E; Pérez-García R; Rodríguez-Benítez P; Ortega M; Martínez Miguel P; Jofré R; López-Gómez JM
Nefrologia; 2007; 27(6):742-8. PubMed ID: 18336105
[TBL] [Abstract][Full Text] [Related]
31. Effect of sertraline hydrochloride on dialysis hypotension.
Dheenan S; Venkatesan J; Grubb BP; Henrich WL
Am J Kidney Dis; 1998 Apr; 31(4):624-30. PubMed ID: 9531178
[TBL] [Abstract][Full Text] [Related]
32. Paraoxonase-1 concentrations in end-stage renal disease patients increase after hemodialysis: correlation with low molecular AGE adduct clearance.
Gugliucci A; Mehlhaff K; Kinugasa E; Ogata H; Hermo R; Schulze J; Kimura S
Clin Chim Acta; 2007 Feb; 377(1-2):213-20. PubMed ID: 17118352
[TBL] [Abstract][Full Text] [Related]
33. Distribution of sertraline in postmortem cases.
Levine B; Jenkins AJ; Smialek JE
J Anal Toxicol; 1994 Sep; 18(5):272-4. PubMed ID: 7990446
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of dyphylline elimination by uremic patients.
Lee CC; Wang LH; Majeske BL; Marbury TC
J Pharmacol Exp Ther; 1981 May; 217(2):340-4. PubMed ID: 7229976
[TBL] [Abstract][Full Text] [Related]
35. Acetazolamide toxicity and pharmacokinetics in patients receiving hemodialysis.
Schwenk MH; St Peter WL; Meese MG; Singhal PC
Pharmacotherapy; 1995; 15(4):522-7. PubMed ID: 7479208
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a carbamic acid ester glucuronide of the secondary amine sertraline.
Tremaine LM; Stroh JG; Ronfeld RA
Drug Metab Dispos; 1989; 17(1):58-63. PubMed ID: 2566471
[TBL] [Abstract][Full Text] [Related]
37. Pharmacology of propylthiouracil in thyrotoxicosis and chronic renal failure.
Cooper DS; Steigerwalt S; Migdal S
Arch Intern Med; 1987 Apr; 147(4):785-6. PubMed ID: 3827468
[TBL] [Abstract][Full Text] [Related]
38. [Pharmacokinetics of trimethoprim and sulfametrol in patients with end stage renal failure and hemodialysis treatment (author's transl)].
Schmidt P; Korn A; Hitzenberger G; Zazgornik J; Kopsa H; Pils P
Wien Med Wochenschr; 1980 Feb; 130(4):171-3. PubMed ID: 7376686
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers.
Ronfeld RA; Tremaine LM; Wilner KD
Clin Pharmacokinet; 1997; 32 Suppl 1():22-30. PubMed ID: 9068932
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of ceftizoxime in patients undergoing hemodialysis.
Shah PM; Knobloch M; Haag R; Kühnle HF
Methods Find Exp Clin Pharmacol; 1982; 4(3):185-8. PubMed ID: 6289027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
